Lijie Ma | Liver Immunology | Research Excellence Award

Published on by Global Scholar Awards

Dr. Lijie Ma | Liver Immunology | Research Excellence Award

Renji Hospital Shanghai Jiao Tong University School of Medicine | China

Dr. Lijie Ma is a clinician-scientist at Fudan University, Shanghai, China, with recognized expertise in surgical oncology, particularly in the management of retroperitoneal sarcoma, hepatobiliary tumors, and complex oncologic surgery. His scholarly work is widely cited and demonstrates sustained influence in high-impact surgical and medical journals. Dr. Ma’s research emphasizes multidisciplinary care models, outcome-driven surgical strategies, and translational approaches, including single-cell analysis, to better understand tumor progression and metastatic mechanisms. He is an active participant in extensive national and international collaborations, contributing to the development of standardized, evidence-based clinical practices. Through the integration of advanced research methodologies and real-world clinical data, Dr. Ma’s work supports improved patient care, optimized surgical outcomes, and meaningful advances in modern cancer management with broad societal relevance.

Citation Metrics (Scopus)

2866
2200
1600
800
0

Citations

2,866

Documents

43

h-index

26

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Sergey Suchkov | Clinical Immunology | Excellence in Innovation Award

Published on by Global Scholar Awards

Prof. Sergey Suchkov | Clinical Immunology | Excellence in Innovation Award

Professor in Medicine and Immunology | N.D. Zelinskii Institute for Organic Chemistry | Russia

Prof. Sergey V. Suchkov, MD, PhD, is a distinguished physician-scientist and international leader in immunology, personalized and precision medicine, and biodesign. Born in Astrakhan, Russia, he graduated with an MD from Astrakhan State Medical University in 1980 and earned his PhD from Sechenov University in 1985, followed by a Doctor’s Degree from the National Institute of Immunology in 2002. His professional experience spans over four decades, including senior research positions at the USSR Academy of Medical Sciences, the Moscow Clinical Research Institute (MONIKI), and leadership roles as Director of the Center for Personalized & Precision Medicine at Sechenov University, Vice-Director of the Institute for Biotech & Global Health at RosBioTech National University, and Director of the Center for Biodesign at N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences. He has contributed to international collaborations, with advanced training and research engagements at the NEI, NIH, USA, Wills Eye Hospital, Philadelphia, and invited work at several British universities under the Royal Society for Immunology. Prof. Suchkov’s research interests include clinical immunology, predictive and preventive medicine, precision nutrition, and translational biodesign, underpinned by skills in immunobiotechnology, personalized therapy design, clinical trial management, and biomedical innovation. He has authored numerous publications in reputed journals and conferences (IEEE, Scopus-indexed) and actively participates in global professional societies including EPMA, ISPM, PMC, ACS, AHA, ARVO, ISER, and AMEE. Recognized for his leadership and contributions to medical education and clinical practice, he has received multiple honors and holds key advisory roles in international research organizations. Prof. Suchkov’s exceptional expertise, global collaborations, and mentorship capacity position him to advance personalized medicine and immunology research worldwide, foster innovation, and continue contributing to healthcare and scientific communities at the highest level, making him a highly deserving candidate for recognition and awards in his field. 989 Citations | 87 Documents | 12 h-index.

Profiles: Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Suchkov, S. V., Revishvili, A. S., Charchyan, E. R., & Belov, Y. V. (2025). Towards highly precise treatment and rehabilitation in practice of modern cardiologist, cardiac surgeon and cardiac rehabilitation professional.

  2. Suchkov, S. V., Charchyan, E. R., Polyakova, V. N., & Belov, Y. V. (2025). On the path to personalized cardiology: prospects of precise assessment of cardiovascular risks and predictive-prognostic diagnostics.

  3. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Human Health, Environmental Comfort and Well-Being. Part 2. Ecological Comfort as a New and Strategic Factor in the Protection of Modern Human Health.

  4. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Human Health, Environmental Comfort and Well-Being. Part 1. Engineering and Design Resources of the Bioindustry on the Way to Safe Competition with the Resources of Natural Biocenoses and Health-Saving Systems.

  5. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Health, Environmental Comfort and Wellbeing through the Integration of Natural and Engineering-Design Bioresources: At the Junction of Pharmaco- and Nutriodesign to the Bioindustry of Tomorrow.

Mahnaz Ghaebi | Immunology | Best Researcher Award

Published on by Global Scholar Awards

Ms. Mahnaz Ghaebi | Immunology | Best Researcher Award

Prospective PhD Student | Zanjan University of Medical Sciences | Iran

Dr. Mahnaz Ghaebi is a medical immunologist and researcher with strong expertise in regenerative medicine, nanotechnology, immunoengineering, biosensors, micro/nanofluidics, and biomaterials. She earned her B.Sc. in Biology from Zanjan University in 2012, graduating as valedictorian and ranked first in her cohort, followed by an M.Sc. in Medical Immunology from Tabriz University of Medical Sciences in 2018, where she completed her thesis on the frequency and epigenetic factors of Treg, Th17, and exhausted T cells in recurrent implantation failure patients. She has enriched her academic training through a Research Internship Course in Pharmaceutical Bioengineering in 2024, covering stem cell design, protein/enzyme engineering, microbial bioengineering, and vaccine design. Professionally, Dr. Ghaebi has served as a Research Assistant at Zanjan University of Medical Sciences (2023–2024), Laboratory Technician during the COVID-19 pandemic, Teaching Assistant guiding students in immunological protocols, and Research Assistant at Tabriz University of Medical Sciences, where she gained hands-on expertise in molecular and cellular biology techniques, flow cytometry, ELISA, and quantitative PCR. Her research interests bridge basic and applied biomedical sciences, with skills extending to bioinformatics, vaccine design, protein modeling, transcriptomic analysis, and computational tools such as R, Python, and Chimera. She has co-authored a book chapter in Springer’s Handbook of Cancer and Immunology and published in reputed journals including Biomedicine & Pharmacotherapy, while also serving as a peer reviewer for international journals such as Survey of Ophthalmology, International Journal of Rheumatic Diseases, and GeroScience. Dr. Ghaebi’s dedication has been recognized with multiple honors, including academic excellence awards, ranking among the top 30 in Iran’s National Entrance Exam for M.Sc., and receiving letters of appreciation for her volunteer leadership during the COVID-19 crisis. Her scholarly contributions reflect growing international recognition, with 1,032 citations by 918 documents, 20 publications, and an h-index of 16.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

  1. Valizadeh, H., Abdolmohammadi-Vahid, S., Danshina, S., Gencer, M. Z., … & Ghaebi, M. (2020). Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. International Immunopharmacology, 89, 107088. Cited by: 306

  2. Ghaebi, M., Nouri, M., Ghasemzadeh, A., Farzadi, L., Jadidi-Niaragh, F., Ahmadi, M., … & Yousefi, M. (2017). Immune regulatory network in successful pregnancy and reproductive failures. Biomedicine & Pharmacotherapy, 88, 61–73. Cited by: 173

  3. Tahmasebi, S., Qasim, M. T., Krivenkova, M. V., Zekiy, A. O., Thangavelu, L., … & Ghaebi, M. (2021). The effects of oxygen–ozone therapy on regulatory T‐cell responses in multiple sclerosis patients. Cell Biology International, 45(7), 1498–1509. Cited by: 170

  4. Ahmadi, M., Abdolmohammadi-Vahid, S., Ghaebi, M., Aghebati-Maleki, L., Afkham, A., Danaii, S., … & Yousefi, M. (2017). Effect of intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL). Biomedicine & Pharmacotherapy, 92, 1095–1102. Cited by: 103

  5. Ghaebi, M., Osali, A., Valizadeh, H., Roshangar, L., & Ahmadi, M. (2020). Vaccine development and therapeutic design for 2019‐nCoV/SARS‐CoV‐2: Challenges and chances. Journal of Cellular Physiology, 235(12), 9098–9109. Cited by: 86

Mehdi Yousefi | Immunology and Microbiology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Mehdi Yousefi | Immunology and Microbiology | Best Researcher Award

Professsor at Tabriz University of Medical Sciences, Iran

Prof. Mehdi Yousefi, Associate Professor of Immunology at Tabriz University of Medical Sciences, is a distinguished researcher with an exceptional track record in immunology, reproductive immunology, autoimmune diseases, and cancer immunotherapy. With over a decade of academic and research experience, Prof. Yousefi has published extensively in high-impact journals, earning a Scopus H-index of 58 and a Google Scholar H-index of 71, placing him among the top 1% of highly cited researchers globally. His innovative contributions include several patents on human antibody fragments and advanced biomedical tools, reflecting his strong focus on translational research. Prof. Yousefi has been recognized multiple times as a Top Researcher by Tabriz University of Medical Sciences and has received the prestigious national Razi Award. Through his leadership, collaborative research, and commitment to advancing immunological science, Prof. Yousefi has made significant contributions to both basic and applied biomedical research, enhancing the scientific community’s understanding of immune-related diseases.

Professional Profile 

Education

Prof. Mehdi Yousefi has a strong and distinguished educational background in medical sciences, particularly in immunology. He earned his Bachelor’s degree (B.Sc.) in Medical Laboratory Technology from Tehran University of Medical Sciences in 2004, where he demonstrated academic excellence. He continued his studies at the same university, completing his Master’s degree (M.Sc.) in Immunology in 2007, where he ranked first in the national entrance exam for the program. Building on his passion for immunological research, Prof. Yousefi pursued a PhD in Immunology, also at Tehran University of Medical Sciences, and graduated in 2013 with the highest possible score (20 out of 20). His PhD research focused on humoral immune responses against tetanus toxin at the single-cell level, showcasing his expertise in immunological techniques and innovative approaches to studying immune mechanisms. His consistent academic excellence, top rankings, and commitment to scientific research laid a strong foundation for his successful career in immunology and medical sciences.

Professional Experience

Prof. Mehdi Yousefi has built an impressive professional career rooted in both academic excellence and cutting-edge research. Since 2013, he has served as an academic and research member at the Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, where he currently holds the position of Associate Professor of Immunology. His professional focus spans a wide range of areas, including reproductive immunology, autoimmune diseases, rheumatic disorders, and cancer immunotherapy. Prof. Yousefi has played a pivotal role in mentoring students, leading collaborative research projects, and contributing to the development of advanced immunological diagnostics and therapies. His innovative work has resulted in numerous patents, particularly in the field of antibody fragment development and cancer targeting, demonstrating his ability to bridge fundamental science with clinical applications. Through his leadership, prolific publications, and active participation in the scientific community, Prof. Yousefi has established himself as a respected and influential figure in immunology research.

Research Interest

Prof. Mehdi Yousefi’s research interests focus on understanding the complex mechanisms of the immune system and its role in health and disease. His primary areas of interest include reproductive immunology, where he investigates the immune system’s involvement in pregnancy complications and maternal-fetal tolerance. He also conducts extensive research on autoimmune diseases and rheumatic disorders, aiming to uncover the immunopathological mechanisms driving these conditions to develop more targeted therapies. In addition, Prof. Yousefi has a strong focus on cancer immunotherapy, particularly the development of novel antibody fragments and immunomodulatory approaches for treating cancers such as breast and colorectal cancer. His work also extends to neurosciences, where he explores the immune system’s interactions with the nervous system in neuroinflammatory and neurodegenerative diseases. Through his multidisciplinary approach, combining basic immunology, translational research, and clinical applications, Prof. Yousefi aims to advance immunological knowledge and develop innovative diagnostic and therapeutic strategies for immune-related disorders.

Award and Honor

Prof. Mehdi Yousefi has received numerous prestigious awards and honors, recognizing his outstanding contributions to immunology and biomedical research. He has been repeatedly honored as the Top Researcher at Tabriz University of Medical Sciences in 2014, 2015, 2017, 2020, and 2021, reflecting his consistent excellence in scientific output and impactful research projects. In 2020, he was further recognized at the national level with the prestigious Razi Award, one of the highest honors for medical research in Iran. In 2022, Prof. Yousefi’s global impact was highlighted when he was named among the Top 1% Highly Cited Researchers (ESI), a distinction that underscores the international significance and influence of his publications. These accolades, combined with his numerous patents and his leadership in innovative research projects, demonstrate Prof. Yousefi’s dedication, creativity, and commitment to advancing immunological science, both within Iran and on the global stage.

Research skill

Prof. Mehdi Yousefi possesses a diverse and advanced set of research skills that have enabled him to excel in the fields of immunology, molecular biology, and translational medicine. His expertise includes designing and conducting immunological assays, such as flow cytometry, ELISA, and cell culture techniques, which he applies to study immune responses in conditions ranging from autoimmune diseases to cancer immunotherapy. He has extensive experience in monoclonal antibody development, including phage display technology for the generation of scFv antibody fragments, which has led to several patents. Prof. Yousefi is also skilled in molecular techniques, such as PCR, gene cloning, and gene expression analysis, which he applies to study immune signaling pathways and immune cell interactions. His collaborative approach, combined with strong project management and scientific writing skills, has resulted in numerous high-impact publications and successful research collaborations, making him a well-rounded and innovative researcher in the field of immunology.

Conclusion

His exceptional publication record, high citation impact, consistent institutional and national awards, and innovative patented research make him a top candidate. His breadth of expertise, from immunology to translational medicine, and his proven track record of impactful research across various fields position him strongly for this recognition

Publications Top Noted

  • The effect of vitamin D supplementation and vaginal probiotics on fertility in women with recurrent implantation failure: A randomized clinical trial
    Authors: Badihi E., Sharifi P., Kamrani A., Aghebati-Maleki L., Yousefi M.
    Journal: Human Immunology
    Year: 2025
    Citations: 0

  • Impact of lymphocyte immunotherapy (LIT) on fertility rates in recurrent pregnancy loss (RPL) women with antinuclear antibodies: A randomized clinical trial
    Authors: Dashti M., Kamrani A., Shahir-Khajeh Z., Mehdizadeh A., Yousefi M.
    Journal: Journal of Reproductive Immunology
    Year: 2025
    Citations: 0

  • Intradermal lymphocyte therapy: A promising treatment for recurrent pregnancy loss in patients without anti-TPO antibodies
    Authors: Ebrahimi R., Asghari K.M., Alamdary S.J., Hojjat-Farsangi M., Yousefi M.
    Journal: Human Immunology
    Year: 2025
    Citations: 0

  • The role of probiotics in restoring the Th1 to Th2 ratio in women experiencing recurrent implantation failure; a double-blind randomized clinical trial
    Authors: Kamrani A., Asghari K.M., Zafarani Y., Zolfaghari M.A., Yousefi M.
    Journal: Human Immunology
    Year: 2025
    Citations: 0

  • Investigating the effect of echinacea extraction syrup on the outcomes of lower respiratory infections in patients with COVID-19: a randomized clinical trial study
    Authors: Kheirandish E., Mahdizadeh M., Mahdizadeh M., Yousefi M., Shojaee S.S.R.
    Journal: Virology Journal
    Year: 2024
    Citations: 0

  • Cyclosporine and fedratinib combination therapy via modulating Th17/Treg balance in Rat model of membranous glomerulonephritis
    Authors: Ghassabi A., Hosseini M., Abdoli Goungormaz H., Etemadi J., Yousefi M.
    Journal: Biochemistry and Biophysics Reports
    Year: 2024
    Citations: 0

  • The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha
    Authors: Sadeghi M., Moslehi A., Kheiry H., Movassaghpuor A.A., Niaragh F.J.
    Journal: Cancer Cell International
    Year: 2024
    Citations: 2

  • Evaluation of changes in exhausted T lymphocytes and miRNAs expression in the different trimesters of pregnancy in pregnant women
    Authors: Shekarchi A.A., Hosseini L., Kamrani A., Ahmadian Heris J., Yousefi M.
    Journal: Molecular Biology Reports
    Year: 2024
    Citations: 0

  • Revolutionized attitude toward recurrent pregnancy loss and recurrent implantation failure based on precision regenerative medicine
    Authors: Asghari K.M., Novinbahador T., Mehdizadeh A., Zolfaghari M.A., Yousefi M.
    Journal: Heliyon
    Year: 2024
    Citations: 0

  • Analysis of Th17 cell population and expression of microRNA and factors related to Th17 in patients with premature ovarian failure
    Authors: Nouri N., Aghebati-Maleki L., Zangbar M.S.S., Chakari-Khiavi F., Yousefi M.
    Journal: Journal of Reproductive Immunology
    Year: 2024
    Citations: 2

Ani Ioana Cotar | Immunology | Best Researcher Award

Published on by Global Scholar Awards

Ani Ioana Cotar | Immunology | Best Researcher Award

PhD, senior researcher at Cantacuzino Research Institute, Romania.

Dr. Ani Ioana Cotar is a distinguished research scientist and head of the National Center for Expertise and Intervention in Public Health for Biological, Chemical, Radiological, and Nuclear Agents at the “Cantacuzino” National Medico-Military Institute in Bucharest, Romania. Her career spans over 20 years, specializing in virology and vector-borne infections, including high-impact diseases such as West Nile, Zika, and Chikungunya viruses. Her expertise in molecular diagnostics and pathogen characterization has positioned her at the forefront of infectious disease research, with extensive experience in immunology and molecular biology techniques. Dr. Cotar’s significant role in global health initiatives is underscored by her work with the EVDLabNet and WHO in external quality assurance (EQA) schemes. Her commitment to advancing public health and her innovative research approaches make her a prominent figure in the field, with her contributions directly impacting diagnostic accuracy and understanding of viral pathogen epidemiology.

Professional Profile

Education

Dr. Cotar’s educational background includes a Ph.D. in Biology from the Faculty of Biology, University of Bucharest, completed in 2009. She holds an MSc in Genetics from the same institution and a BSc in Biology. Additionally, she completed two postdoctoral fellowships; one at the University of Bucharest, where she deepened her understanding of molecular biology, and the other under the European Program for Public Health Microbiology (EUPHEM) in Stockholm. This extensive education laid the groundwork for her career in vector-borne infections and public health. Her advanced studies, particularly in molecular epidemiology, prepared her for her pioneering role in pathogen identification and control. Dr. Cotar’s academic accomplishments highlight her commitment to integrating science with public health practices to improve diagnostic protocols and preventive strategies against infectious diseases.

Professional Experience

Dr. Cotar began her career at the “Cantacuzino” Institute in 2001 as a biologist and progressed to roles of increasing responsibility, becoming a Research Scientist I by 2022 and Head of the National Center in 2023. Her experience includes leading projects on the molecular diagnostics of high-risk vector-borne pathogens and implementing quality assurance testing for the WHO. Her work includes crucial contributions to SARS-CoV-2 diagnostics during the pandemic and coordinating whole-genome sequencing for bacterial pathogens. She has developed protocols for DNA/RNA extraction, PCR, and real-time PCR, bringing rigorous scientific standards to her laboratory’s practices. Her leadership and technical expertise have contributed to significant advancements in Romania’s capacity to detect, monitor, and respond to infectious disease threats, particularly in vector-borne pathogens affecting both national and global health landscapes.

Research Interest

Dr. Cotar’s research interests lie in the molecular epidemiology and diagnostics of viral and bacterial vector-borne pathogens. Her work focuses on identifying and characterizing infectious agents such as West Nile, Zika, and Chikungunya viruses, as well as bacterial pathogens like Rickettsia and Borrelia. She is committed to improving diagnostic capabilities through molecular biology techniques, including PCR, DNA sequencing, and bioinformatics. Dr. Cotar’s research extends to quality assurance, participating in global quality initiatives that enhance laboratory accuracy for pathogen detection. Her expertise in molecular typing and genome sequencing reflects her focus on understanding pathogen transmission, evolution, and resistance, critical for developing effective public health interventions.

Award and Honor

Dr. Cotar has been recognized for her contributions to public health and infectious disease research. Her work on the frontlines of SARS-CoV-2 diagnostics and her efforts to establish protocols for emerging viral and bacterial pathogens have earned her respect within the scientific community. She has received accolades for her role in quality assurance initiatives with the WHO and her contributions to the EVDLabNet. These recognitions underscore her commitment to improving diagnostic accuracy and public health response capabilities, and her dedication has positioned her as an authority in virology and infectious disease research in Romania and beyond.

Conclusion

Dr. Cotar’s deep specialization in vector-borne infectious diseases, coupled with her proven track record in molecular diagnostics and quality assurance, establishes her as a leading candidate for the Best Researcher Award. Her consistent contributions are essential to advancing both national and global health research on infectious diseases.

Publications top noted

Title: Increasing the Awareness of Under-Diagnosed Tropical Cases of Dengue in Romania
Authors: Cismaru, I.M., Radu, M.A., Cotar, A.I., Ghemulet, I., Gheorghita, V.
Year: 2023
Citation: Tropical Medicine and Infectious Disease, 2023, 8(10), 469.

Title: First Detection and Molecular Characterization of Usutu Virus in Culex pipiens Mosquitoes Collected in Romania
Authors: Prioteasa, F.L., Dinu, S., Tiron, G.V., Ceianu, C.S., Cotar, A.I.
Year: 2023
Citation: Microorganisms, 2023, 11(3), 684.

Title: Distribution of Insecticide Resistance Genetic Markers in the West Nile Virus Vector Culex pipiens from South-Eastern Romania
Authors: Stancu, I.G., Prioteasa, F.L., Tiron, G.V., Ceianu, C.S., Csutak, O.
Year: 2022
Citation: Insects, 2022, 13(11), 1062.

Title: Original Contributions to the Chemical Composition, Microbicidal, Virulence-Arresting, and Antibiotic-Enhancing Activity of Essential Oils from Four Coniferous Species
Authors: Visan, D.-C., Oprea, E., Radulescu, V., Chifiriuc, M.C., Marinas, I.C.
Year: 2021
Citation: Pharmaceuticals, 2021, 14(11), 1159.

Title: Characterization and Host-Feeding Patterns of Culex pipiens s.l. Taxa in a West Nile Virus-Endemic Area in Southeastern Romania
Authors: Tiron, G.V., Stancu, I.G., Dinu, S., Ceianu, C.S., Cotar, A.I.
Year: 2021
Citation: Vector-Borne and Zoonotic Diseases, 2021, 21(9), pp. 713–719.

Title: Emergence of Toscana Virus, Romania, 2017-2018
Authors: Popescu, C.P., Cotar, A.I., Dinu, S., Ceianu, C.S., Florescu, S.A.
Year: 2021
Citation: Emerging Infectious Diseases, 2021, 27(5), pp. 1482–1485.

Title: Increased Risk of Chikungunya Infection in Travelers to Thailand During Ongoing Outbreak in Tourist Areas: Cases Imported to Europe and the Middle East, Early 2019
Authors: Javelle, E., Florescu, S.-A., Asgeirsson, H., Hamer, D.H., Gautret, P.
Year: 2019
Citation: Eurosurveillance, 2019, 24(10), 1900146.

Title: West Nile Virus Lineage 2 in Romania, 2015-2016: Co-Circulation and Strain Replacement
Authors: Cotar, A.I., Fǎlcuţǎ, E., Dinu, S., Ceianu, C.S., Prioteasa, F.L.
Year: 2018
Citation: Parasites and Vectors, 2018, 11(1), 562.

Title: Re-Emergence of Severe West Nile Virus Neuroinvasive Disease in Humans in Romania, 2012 to 2017 – Implications for Travel Medicine
Authors: Popescu, C.P., Florescu, S.A., Cotar, A.I., Ceausu, E., Ruta, S.M.
Year: 2018
Citation: Travel Medicine and Infectious Disease, 2018, 22, pp. 30–35.

Title: Lack of Zika Virus Antibody Response in Confirmed Patients in Non-Endemic Countries
Authors: Lustig, Y., Cotar, A.I., Ceianu, C.S., Aarons, E., Reusken, C.
Year: 2018
Citation: Journal of Clinical Virology, 2018, 99-100, pp. 31–34.

Abdolghaffar Ownagh | Immunology and Microbiology | Best Researcher Award

Published on by Global Scholar Awards

Prof Dr. Abdolghaffar Ownagh | Immunology and Microbiology | Best Researcher Award

Professor in microbiology Department at Urmia University, Iran

Prof. Dr. Abdolghaffar Ownagh is a distinguished academic and researcher in the field of veterinary microbiology, currently serving as a Professor in the Department of Microbiology at Urmia University, Iran. He holds a DVM and a DVSc in Microbiology, with extensive teaching experience spanning over three decades, covering courses in veterinary and medical mycology, bacteriology, and general microbiology. Dr. Ownagh has made significant contributions to the field, authoring numerous publications focused on microbial pathogenesis and the use of natural products in veterinary medicine. His research includes molecular detection of pathogens and antifungal treatments, showcasing a commitment to advancing veterinary science. Additionally, he has supervised the theses of multiple PhD and MSc students, fostering the development of future researchers. Dr. Ownagh’s expertise and dedication to teaching and research position him as a leading figure in veterinary microbiology, making substantial contributions to both academia and the scientific community.

Professional Profile

Education

Prof. Dr. Abdolghaffar Ownagh has a robust educational background in veterinary medicine and microbiology. He obtained his Doctor of Veterinary Medicine (DVM) degree from Urmia University, Iran, from 1987 to 1992, where he conducted his thesis on colibacillar diarrhea in calves. He furthered his studies by earning a Doctorate of Veterinary Science (DVSc) in Microbiology from the same institution between 2001 and 2007, focusing on the effects of various essential oils on fungi associated with Artemia urmiana. This comprehensive education has provided Dr. Ownagh with a solid foundation in veterinary science and microbiological research. His academic journey reflects a deep commitment to the field, equipping him with the necessary expertise to excel in teaching and research. Dr. Ownagh’s educational credentials have significantly contributed to his role as a leading figure in veterinary microbiology at Urmia University, where he continues to inspire and mentor future professionals in the field.

Professional Experience

Prof. Dr. Abdolghaffar Ownagh has amassed extensive professional experience in academia and research over his three-decade career. He is currently a Professor in the Department of Microbiology at Urmia University, Iran, where he has been instrumental in teaching a wide range of subjects, including veterinary and medical mycology, bacteriology, and general microbiology for DVM, MSc, and PhD students since 1993. In addition to his teaching responsibilities, Dr. Ownagh has supervised over 50 graduate and postgraduate theses, demonstrating his commitment to nurturing the next generation of researchers in veterinary sciences. His research efforts focus on microbial pathogenesis, antifungal treatments, and the application of natural products in veterinary medicine. Dr. Ownagh’s leadership in academia and his dedication to advancing knowledge in veterinary microbiology have established him as a prominent figure in his field, contributing significantly to both education and research initiatives at Urmia University.

Research Interest

Prof. Dr. Abdolghaffar Ownagh’s research interests encompass a broad spectrum within veterinary microbiology, with a strong emphasis on microbial pathogenesis and the exploration of natural products for therapeutic applications. His work primarily investigates the molecular detection and phylogenetic analysis of various pathogens affecting livestock, particularly focusing on zoonotic diseases and their impact on animal and human health. Dr. Ownagh has conducted significant research on the antifungal properties of essential oils and natural extracts, such as propolis, evaluating their effectiveness against fungal infections in veterinary settings. His studies also include the characterization of antibiotic resistance in bacterial pathogens and the development of innovative treatments for infections in animals. By integrating microbiological research with practical veterinary applications, Dr. Ownagh aims to enhance disease management strategies in livestock and contribute to the overall improvement of animal health and welfare. His commitment to advancing knowledge in this field positions him as a key contributor to veterinary science.

Award and honor

Prof. Dr. Abdolghaffar Ownagh has received several awards and honors throughout his distinguished academic and research career, recognizing his contributions to veterinary microbiology and education. His commitment to excellence in teaching has been acknowledged by the faculty at Urmia University, where he has played a pivotal role in shaping the curriculum and mentoring students at various academic levels. Dr. Ownagh’s research contributions have also garnered recognition within the scientific community, particularly for his innovative studies on microbial pathogenesis and the application of natural products in veterinary medicine. He has published extensively in reputable journals, earning accolades for his significant findings in the field. Additionally, Dr. Ownagh’s efforts to supervise and guide numerous graduate students have contributed to the development of future researchers, further solidifying his reputation as a dedicated educator and leader. These awards and honors reflect his unwavering dedication to advancing knowledge and improving practices within veterinary sciences.

Conclusion

Abdolghaffar Ownagh demonstrates strong qualifications for the Best Researcher Award, reflecting his extensive academic and research background, a significant body of work in microbiology, and a commitment to teaching and mentoring. By focusing on interdisciplinary collaborations, increasing his publication footprint, and pursuing more funding opportunities, he can further elevate his impact in the field of veterinary microbiology. His contributions are invaluable, making him a strong candidate for recognition in this prestigious award.

Publications top noted

  1. 🦠 Molecular survey and phylogenetic analysis of Bartonella henselae and Bartonella clarridgeiae in dogs from northwest Iran
    Rajabi, S.A., Ownagh, A., Hadian, M.
    Journal of Zoonotic Diseases, 2024, 8(4), pp. 610–620
  2. 🔬 Molecular and genotyping techniques in diagnosis of Coxiella burnetii: An overview
    Khademi, P., Tukmechi, A., Sgroi, G., Khalili, M., Mardani, K.
    Infection, Genetics and Evolution, 2024, 123, 105655
  3. 🐾 Molecular detection and phylogenetic analysis of Borrelia spp. in blood samples of cats and dogs by the nested-PCR method in West Azerbaijan Province, Iran
    Ownagh, A., Rajabi, S.A., Enferadi, A., Hadian, M.
    Brazilian Journal of Microbiology, 2024, 55(3), pp. 2915–2922
  4. 💧 Identification of a lytic bacteriophage against clinical isolates of Salmonella typhimurium in turkey poults
    Amini, M., Ownagh, A., Tukmechi, A., Allymehr, M.
    Veterinary Research Forum, 2024, 15(6), pp. 309–316
  5. 🐦 Molecular and histopathological survey of Francisella spp., Borrelia spp. and Leptospira spp. in ornamental birds of four provinces of Iran
    Enferadi, A., Ownagh, A., Nofouzi, K., Khordadmehr, M.
    Gene Reports, 2024, 35, 101921
  6. 🌱 Application of Propolis Ethanol Extract and Propolis Nanoemulsion in Treatment of Cutaneous Infection in Rabbit
    Archin, T., Ownagh, A., Tehrani, A.A., Keshipour, S.
    Iranian Journal of Veterinary Surgery, 2024, 19(1), pp. 8–18
  7. 🐄 Therapeutic effects of propolis ethanolic extract on infectious bovine keratoconjunctivitis in cows
    Bahmani, T., Najarnezhad, V., Ownagh, A.
    Journal of Advanced Veterinary Research, 2024, 14(4), pp. 586–590
  8. 🦎 First molecular detection of Francisella tularensis in turtle (Testudo graeca) and ticks (Hyalomma aegyptium) in Northwest of Iran
    Tukmechi, A., Ownagh, A., Enferadi, A., Khademi, P.
    International Journal for Parasitology: Parasites and Wildlife, 2024, 23, 100892
  9. 🐑 Molecular detection and phylogenetic analysis of Borrelia spp. from sheep and goats blood samples in West Azerbaijan province, Iran
    Enferadi, A., Ownagh, A., Tavassoli, M.
    Veterinary Research Forum, 2024, 15(2), pp. 89–95
  10. 🐱 Genomic detection and phylogenetic analysis of Bartonella quintana in pet cats from Urmia City, Northwest Iran
    Rajabi, S.A., Ownagh, A., Hadian, M.
    Comparative Immunology, Microbiology and Infectious Diseases, 2024, 105, 102125

Jean-nicolas boursiquot | Immunology | Best Researcher Award

Published on by Global Scholar Awards

🌟Dr. Jean-nicolas boursiquot, Immunology, Best Researcher Award 🏆

  •  Doctorate at CHU de Quebec, Canada
 

Jean-Nicolas Boursiquot is a highly qualified medical professional specializing in allergy and clinical immunology. With a comprehensive educational background and extensive research experience, Boursiquot has made significant contributions to the field through publications, presentations, and teaching activities. His dedication to advancing medical knowledge and patient care is evident in his multifaceted professional journey, marked by numerous affiliations, academic commitments, and media engagements. Boursiquot’s expertise encompasses a wide range of topics within allergy and immunology, making him a respected figure in both academic and clinical settings.

Author Metrics:

Scopus Profile

Boursiquot’s author metrics reflect a prolific and impactful academic career, with a substantial number of publications in peer-reviewed journals, presentations at scientific conferences, and media engagements.

  • Citations: 385 citations by 385 documents
  • Documents: 9
  • h-index: 5

Education:

  • Ph.D. in Medicine (M.D.), Laval University, Quebec, Canada, 1999-2004
  • Intensive ESL (English as Second Language) Training, University of Manitoba, Winnipeg, Canada, 1999
  • International Baccalaureate (Pure Sciences), Small Seminary of Quebec, Quebec, Canada, 1997-1999

Research Focus:

Boursiquot’s research focuses primarily on allergy and clinical immunology, with particular interests in immunodeficiencies, allergic rhinitis, asthma, drug allergies, and angioedema. He has conducted studies on various aspects of these conditions, contributing to advancements in diagnosis, treatment, and understanding of underlying mechanisms.

Professional Journey:

Boursiquot’s professional journey spans diverse roles in academia, clinical practice, research, and education:

  • Clinical Allergist and Immunologist at CSSS DES ILES and CSSS DE LAC-SAINT-JEAN-EST
  • Clinical Professor and Educational Ambassador at Laval University
  • Member of various professional committees and boards, including the Canadian Society of Allergy and Clinical Immunology (CSACI) and the Association of Allergists and Immunologists of Quebec (AAIQ)
  • Active involvement in medical education and training, including teaching medical students, residents, and clinicians

Honors & Awards:

  • Recipient of the CMDP of CHUQ and CHUQ-CMDP Foundation Award in 2010
  • Awarded the Humanism Prize in 1997 by the Small Seminary of Quebec

Research Timeline:

1999-2004: Pursued Ph.D. in Medicine at Laval University, Quebec, Canada

2007-2009: Completed Residency in Allergy and Clinical Immunology at McGill University, Montreal, Canada

2010: Conducted Research Fellowship at Pr Éric Oksenhendler Service, St-Louis Hospital, Paris, France

2013-present: Actively engaged in clinical practice, research, teaching, and professional development, making significant contributions to the field of allergy and clinical immunology.

Publications Noted & Contributions:

Boursiquot has made significant contributions to the medical literature through published articles, scientific posters, and presentations at conferences. His research has been focused on topics such as immunodeficiencies, allergic reactions, and treatment strategies. He has also engaged with the media to raise awareness and educate the public about allergies and related conditions.

Safety of Direct Drug Provocation for the Evaluation of Penicillin Allergy in Low-Risk Adults

  • Authors: Brillant-Marquis, F., Proulx, É., Ratnarajah, K., De Serres, G., Drolet, J.-P., Boursiquot, J.-N.
  • Journal: Journal of Allergy and Clinical Immunology: In Practice, 2024, 12(2), pp. 451–457.e2
  • Abstract: [Not available]
  • Citations: 1
  • Note: Open access

A Patient Charter for Chronic Urticaria

  • Authors: Maurer, M., Albuquerque, M., Boursiquot, J.-N., Nigen, S., Winders, T.
  • Journal: Advances in Therapy, 2024, 41(1), pp. 14–33
  • Abstract: [Not available]
  • Citations: 0
  • Review: Open access

Bradykinin-induced angioedema in the emergency department

  • Authors: Hébert, J., Boursiquot, J.-N., Chapdelaine, H., Lepeshkina, O., Vincent, M.
  • Journal: International Journal of Emergency Medicine, 2022, 15(1), 15
  • Abstract: [Not available]
  • Citations: 2
  • Erratum: Open access

Erratum: The International/Canadian Hereditary Angioedema Guideline

  • Authors: Betschel, S., Badiou, J., Binkley, K., Stark, D., Tsai, E.
  • Journal: Allergy, Asthma and Clinical Immunology, 2020, 16(1), 16
  • Abstract: [Not available]
  • Citations: 1
  • Erratum: Open access

Patient and physician perceptions of seasonal allergic rhinitis and allergen immunotherapy: A parallel physician-patient survey

  • Authors: Ellis, A.K., Boursiquot, J., Carr, S., Graham, F., Masse, M.-S.
  • Journal: Allergy, Asthma and Clinical Immunology, 2020, 16(1), 15
  • Abstract: [Not available]
  • Citations: 8